Skip to main content

UBS Group AG

Position in MYGN — Myriad Genetics Inc

CIK 1610520 ZURICH, V8

Position in MYGN

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$3,164,251
-$769,847 QoQ
Shares Held
703,167
+9.9% QoQ
Ownership
0.745%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Derivatives in MYGN

reported options exposure · as of Mar 31, 2020
CallValue
$0
CallShares
0
PutValue
$1,431
PutShares
100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

UBS Group AG holds $3,683,964,878 across 46 Diagnostics & Research names. MYGN ranks #27 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MYGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,164,251 703,167
2025-12-31 $3,934,098 639,691
2025-09-30 $3,561,830 492,646
2025-06-30 $4,232,037 796,994
2025-03-31 $4,865,177 548,498
2024-12-31 $6,547,511 477,572
2024-09-30 $5,586,435 203,959
2024-06-30 $2,981,356 121,887
2024-03-31 $4,482,934 210,269
2023-12-31 $3,231,137 168,816
2023-09-30 $1,134,989 70,760
2023-06-30 $2,562,340 110,541
2023-03-31 $1,779,161 76,589
2022-12-31 $2,670,607 184,053
2022-09-30 $663,449 34,772
2022-06-30 $689,768 37,962
2022-03-31 $3,549,142 140,839
2021-12-31 $5,017,403 181,790
2021-09-30 $3,220,894 99,749
2021-06-30 $352,740 11,535
2021-03-31 $3,274,105 107,524
2020-12-31 $1,723,983 87,202
2020-09-30 $172,192 13,205
2020-06-30 $96,729 8,530
2020-03-31 $502,151 35,091
2020-03-31 $1,431 100